45
Participants
Start Date
April 14, 2011
Primary Completion Date
May 19, 2021
Study Completion Date
May 19, 2021
Bevacizumab
10 mg/kg by vein once every 2 weeks on days 1 and 15 of each cycle. The first dose of bevacizumab will be given over about 90 minutes
Erlotinib
150 mg by mouth once a day.
University of Texas MD Anderson Cancer Center, Houston
Collaborators (2)
Genentech, Inc.
INDUSTRY
OSI Pharmaceuticals
INDUSTRY
M.D. Anderson Cancer Center
OTHER